Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Friis-Liby

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Gastroenterology|October 30, 2004
High prevalence of metabolic complications in patients with non-alcoholic fatty liver diseaseI Friis-Liby, F Aldenborg, P Jerlstad, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2010
Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab studyA Gustavsson, G Järnerot, E Hertervig, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2012
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasiaL Lindström, K M Boberg, O Wikman, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2013
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patientsM Sjöberg, A Magnuson, J Björk, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Gastroenterology|October 30, 2004
High prevalence of metabolic complications in patients with non-alcoholic fatty liver diseaseI Friis-Liby, F Aldenborg, P Jerlstad, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2010
Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab studyA Gustavsson, G Järnerot, E Hertervig, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2012
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasiaL Lindström, K M Boberg, O Wikman, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2013
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patientsM Sjöberg, A Magnuson, J Björk, et al.
Pageof 1